•
CL
CLLS
Cellectis S.A. American Depositary Shares
yahoo--
Price Chart
Market Cap
412.34M
Volume
36.57K
52W High
$5.48
52W Low
$1.10
Open
$0.00
Prev Close
$4.15
Day Range
0.00 - 0.00
About Cellectis S.A. American Depositary Shares
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Latest News
Allogene Arbitration Victory Pressures Cellectis Shares Tuesday
Benzinga•Dec 16
Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis
GlobeNewswire Inc.•Dec 15
ASH 2025 : Cellectis présente son plan de développement pour renforcer les taux de réponse élevés obtenus avec éti-cel dans le LNH en rechute ou réfractaire
GlobeNewswire Inc.•Dec 8
ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL
GlobeNewswire Inc.•Dec 8
Cellectis présente sa stratégie « Smart CAR T » pour améliorer l’efficacité contre les tumeurs solides à l’AACR-IO 2025
GlobeNewswire Inc.•Feb 24
Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025
GlobeNewswire Inc.•Feb 24
Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer
GlobeNewswire Inc.•Jan 28
Monthly information on share capital and company voting rights
GlobeNewswire Inc.•Oct 2